280
Views
17
CrossRef citations to date
0
Altmetric
Reviews

The future potential for cocaine vaccines

, MD, , PhD, , PhD, , PhD, , PhD, , PhD, , PhD & , MD show all

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Eduardo R. Butelman & Mary Jeanne Kreek. (2017) Medications for substance use disorders (SUD): emerging approaches. Expert Opinion on Emerging Drugs 22:4, pages 301-315.
Read now
Marco Pravetoni. (2016) Biologics to treat substance use disorders: Current status and new directions. Human Vaccines & Immunotherapeutics 12:12, pages 3005-3019.
Read now
Kenneth Blum, Peter K Thanos, Rajendra D Badgaiyan, Marcelo Febo, Marlene Oscar-Berman, James Fratantonio, Zsolt Demotrovics & Mark S Gold. (2015) Neurogenetics and gene therapy for reward deficiency syndrome: are we going to the Promised Land?. Expert Opinion on Biological Therapy 15:7, pages 973-985.
Read now

Articles from other publishers (14)

Rachel J. Stephenson & Istvan Toth. (2023) Anti-cocaine Vaccine Development: Where Are We Now and Where Are We Going?. Journal of Medicinal Chemistry 66:11, pages 7086-7100.
Crossref
Cheng Hua. 2023. Frontiers in Clinical Drug Research - CNS and Neurological Disorders: Volume 11. Frontiers in Clinical Drug Research - CNS and Neurological Disorders: Volume 11 158 237 .
Brian Sabato, Paulo Sérgio de Almeida Augusto, Raissa Lima Gonçalves Pereira, Felipe Coutinho Batista Esteves, Sordaini M. Caligiorne, Bruna Rodrigues Dias Assis, Sóstenes Apolo Correia Marcelino, Larissa Pires do Espírito Santo, Karine Dias dos Reis, Leonardo Da Silva Neto, Gisele Goulart, Ângelo de Fátima, Felipe Pierezan, Ricardo Toshio Fujiwara, Maila Castro & Frederico Garcia. (2023) Safety and immunogenicity of the anti-cocaine vaccine UFMG-VAC-V4N2 in a non-human primate model. Vaccine 41:13, pages 2127-2136.
Crossref
Kenneth Blum, Abdalla Bowirrat, Luis Llanos Gomez, B. William Downs, Debasis Bagchi, Debmalya Barh, Edward J. Modestino, David Baron, Thomas McLaughlin, Panayotis Thanos, Mauro Ceccanti, Igor Elman, Rajendra D. Badgaiyan, Catherine Dennen, Ashim Gupta, Eric R. Braverman & Mark S. Gold. (2022) Why haven't we solved the addiction crisis?. Journal of the Neurological Sciences 442, pages 120404.
Crossref
Paulo Sérgio de Almeida Augusto, Raissa Lima Gonçalves Pereira, Sordaini Maria Caligiorne, Brian Sabato, Bruna Rodrigues Dias Assis, Larissa Pires do Espírito Santo, Karine Dias dos Reis, Gisele Assis Castro Goulart, Ângelo de Fátima, Maila de Castro Lourenço das Neves & Frederico Duarte Garcia. (2021) The GNE-KLH anti-cocaine vaccine protects dams and offspring from cocaine-induced effects during the prenatal and lactating periods. Molecular Psychiatry 26:12, pages 7784-7791.
Crossref
Kenneth Blum, Jean Lud Cadet & Mark S. Gold. (2021) Psychostimulant use disorder emphasizing methamphetamine and the opioid -dopamine connection: Digging out of a hypodopaminergic ditch. Journal of the Neurological Sciences 420, pages 117252.
Crossref
Perry M. Duncan. 2020. Substance Use Disorders. Substance Use Disorders.
Fang Yang & Thomas R. Kosten. (2019) Psychopharmacology: neuroimmune signaling in psychiatric disease-developing vaccines against abused drugs using toll-like receptor agonists. Psychopharmacology 236:10, pages 2899-2907.
Crossref
Candy S. Hwang, Paul T. Bremer, Cody J. Wenthur, Sam On Ho, SuMing Chiang, Beverly Ellis, Bin Zhou, Gary Fujii & Kim D. Janda. (2018) Enhancing Efficacy and Stability of an Antiheroin Vaccine: Examination of Antinociception, Opioid Binding Profile, and Lethality. Molecular Pharmaceutics 15:3, pages 1062-1072.
Crossref
M. D. Raleigh, S. J. Peterson, M. Laudenbach, F. Baruffaldi, F. I. Carroll, S. D. Comer, H. A. Navarro, T. L. Langston, S. P. Runyon, S. Winston, M. Pravetoni & P. R. Pentel. (2017) Safety and efficacy of an oxycodone vaccine: Addressing some of the unique considerations posed by opioid abuse. PLOS ONE 12:12, pages e0184876.
Crossref
Jai S. Rudra, Ye Ding, Harshini Neelakantan, Chunyong Ding, Rajagopal Appavu, Sonja Stutz, Joshua D. Snook, Haiying Chen, Kathryn A. Cunningham & Jia Zhou. (2016) Suppression of Cocaine-Evoked Hyperactivity by Self-Adjuvanting and Multivalent Peptide Nanofiber Vaccines. ACS Chemical Neuroscience 7:5, pages 546-552.
Crossref
Karen C. Collins & Kim D. Janda. 2016. Biologics to Treat Substance Use Disorders. Biologics to Treat Substance Use Disorders 327 365 .
Frank M. Orson, Berma M. Kinsey, Reetakshi Arora, Muthu Ramakrishnan & Thomas R. Kosten. 2016. Biologics to Treat Substance Use Disorders. Biologics to Treat Substance Use Disorders 295 307 .
Andrew C. McCreary, Christian P. Müller & Małgorzata Filip. 2015. The Neuropsychiatric Complications of Stimulant Abuse. The Neuropsychiatric Complications of Stimulant Abuse 41 83 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.